- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 221 results
Webinar
5月 20, 2021
Practical Steps to Prepare Your Hospital’s Controlled Substances Diversion Program for Government Scrutiny
Webinar
5月 12, 2021
Personal Jurisdiction Over Life Science Businesses In Light of Recent Supreme Court Decisions
Webinar
5月 5, 2021
The Biden Administration’s First 100 Days: An Analysis of Key Developments in International Trade
Webinar
Webinar
4月 29, 2021
Protecting Your CARES Act Provider Relief Funds During Audit and Enforcement: The Time to Act Is Now
Webinar
4月 28, 2021
Meaghan Griffith to Co-Moderate a Panel About Canada/U.S. Cross-Border Merger Remedies
Webinar
4月 27, 2021
What to Expect From the DOJ in the Biden Administration
Webinar
4月 21, 2021
Key Food and Beverage Issues: Recent Developments in Trademark Infringement and Parody Disputes
Webinar
4月 20, 2021
A Discussion With State Attorneys General About Enforcement Priorities and Policies
Webinar
4月 8, 2021
Current Trends in U.S./Brazilian Cross-Border Investigations
Webinar
3月 31, 2021
LNG Opportunities in Vietnam: Insiders’ Perspectives
Webinar
3月 31, 2021
The Evolving Funds Landscape - the Saudi, Regional and International Perspective